Beta Drugs Limited (NSE:BETA)

India flag India · Delayed Price · Currency is INR
2,366.80
+176.50 (8.06%)
At close: Jul 10, 2026
Market Cap23.89B +34.3%
Revenue (ttm)3.85B +6.2%
Net Income414.83M -2.2%
EPS40.92 -2.6%
Shares Out 10.09M
PE Ratio57.84
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume95,317
Open2,190.30
Previous Close2,190.30
Day's Range2,190.30 - 2,395.00
52-Week Range990.10 - 2,395.00
Beta-0.52
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About Beta Drugs

Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India. [Read more]

Sector Healthcare
Founded 1985
Employees 399
Stock Exchange National Stock Exchange of India
Ticker Symbol BETA
Full Company Profile

Financial Performance

In fiscal year 2026, Beta Drugs's revenue was 3.85 billion, an increase of 6.20% compared to the previous year's 3.62 billion. Earnings were 414.83 million, a decrease of -2.21%.

Financial Statements